| Product Code: ETC12773098 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea NSCLC Therapeutics Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea NSCLC Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea NSCLC Therapeutics Market - Industry Life Cycle |
3.4 South Korea NSCLC Therapeutics Market - Porter's Five Forces |
3.5 South Korea NSCLC Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Korea NSCLC Therapeutics Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 South Korea NSCLC Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 South Korea NSCLC Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 South Korea NSCLC Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-small cell lung cancer (NSCLC) in South Korea |
4.2.2 Advancements in research and development of NSCLC therapeutics |
4.2.3 Growing awareness and adoption of targeted therapies for NSCLC treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for new NSCLC therapeutics |
4.3.2 High costs associated with NSCLC treatment and therapies |
4.3.3 Limited access to specialized healthcare facilities for NSCLC patients in certain regions of South Korea |
5 South Korea NSCLC Therapeutics Market Trends |
6 South Korea NSCLC Therapeutics Market, By Types |
6.1 South Korea NSCLC Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea NSCLC Therapeutics Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 South Korea NSCLC Therapeutics Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.4 South Korea NSCLC Therapeutics Market Revenues & Volume, By Tyrosine Kinase Inhibitors, 2021 - 2031F |
6.1.5 South Korea NSCLC Therapeutics Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.6 South Korea NSCLC Therapeutics Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2 South Korea NSCLC Therapeutics Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 South Korea NSCLC Therapeutics Market Revenues & Volume, By Pembrolizumab, 2021 - 2031F |
6.2.3 South Korea NSCLC Therapeutics Market Revenues & Volume, By Erlotinib, 2021 - 2031F |
6.2.4 South Korea NSCLC Therapeutics Market Revenues & Volume, By Cisplatin, 2021 - 2031F |
6.2.5 South Korea NSCLC Therapeutics Market Revenues & Volume, By Stereotactic Body Radiation, 2021 - 2031F |
6.3 South Korea NSCLC Therapeutics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 South Korea NSCLC Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 South Korea NSCLC Therapeutics Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.3.4 South Korea NSCLC Therapeutics Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.3.5 South Korea NSCLC Therapeutics Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4 South Korea NSCLC Therapeutics Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 South Korea NSCLC Therapeutics Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.4.3 South Korea NSCLC Therapeutics Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.4.4 South Korea NSCLC Therapeutics Market Revenues & Volume, By Advanced Cancer Treatment, 2021 - 2031F |
6.4.5 South Korea NSCLC Therapeutics Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
7 South Korea NSCLC Therapeutics Market Import-Export Trade Statistics |
7.1 South Korea NSCLC Therapeutics Market Export to Major Countries |
7.2 South Korea NSCLC Therapeutics Market Imports from Major Countries |
8 South Korea NSCLC Therapeutics Market Key Performance Indicators |
8.1 Patient survival rates post NSCLC treatment |
8.2 Number of clinical trials conducted for NSCLC therapeutics in South Korea |
8.3 Adoption rate of targeted therapies for NSCLC in major healthcare centers |
9 South Korea NSCLC Therapeutics Market - Opportunity Assessment |
9.1 South Korea NSCLC Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Korea NSCLC Therapeutics Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 South Korea NSCLC Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 South Korea NSCLC Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 South Korea NSCLC Therapeutics Market - Competitive Landscape |
10.1 South Korea NSCLC Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 South Korea NSCLC Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here